DBV Technologies SA (DBVT)
21.06
+0.56
(+2.73%)
USD |
NASDAQ |
Apr 02, 16:00
21.10
+0.04
(+0.19%)
After-Hours: 20:00
DBV Technologies SG&A Expense (Semi Annual)
SG&A Expense (Semi Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Semi Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Semi Annual) Benchmarks
| EDAP TMS SA | -- |
| Cellectis SA | -- |
| Ascendis Pharma A/S | -- |
| Akari Therapeutics Plc | -- |
| Biodexa Pharmaceuticals Plc | 3.292M |